• 1
    Bauer M, Goetz T, Glenn T, Whybrow PC. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol 2008; 20: 11011114.
  • 2
    Extein I, Pottash AL, Gold MS et al. The thyroid-stimulating hormone response to thyrotropin-releasing hormone in mania and bipolar depression. Psychiatry Res 1980; 2: 199204.
  • 3
    Kirkegaard C, Bjorum N, Cohn D, Lauridsen UB. Thyrotrophin-releasing hormone (TRH) stimulation test in manic-depressive illness. Arch Gen Psychiatry 1978; 35: 10171021.
  • 4
    Bauer M, Hellweg R, Gräf KJ, Baumgartner A. Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology 1998; 18: 444455.
  • 5
    Bauer M, London ED, Rasgon N et al. Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry 2005; 10: 456469.
  • 6
    Bauer M, Berghöfer A, Bschor T et al. Supraphysiological doses of L-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders. Neuropsychopharmacology 2002; 27: 620628.
  • 7
    Bauer MS, Whybrow PC. Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psychiatry 1990; 47: 435440.
  • 8
    Baumgartner A, Bauer M, Hellweg R. Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: an open clinical trial. Neuropsychopharmacology 1994; 10: 183189.
  • 9
    Azorin JM, Kaladjian A, Adida M et al. Factors associated with rapid cycling in bipolar I manic patients: findings from a French National Study. CNS Spectr 2008; 13: 780787.
  • 10
    Thomsen AF, Kvist TK, Andersen PK, Kessing LV. Increased risk of developing affective disorder in patients with hypothyroidism: a register-based study. Thyroid 2005; 15: 700707.
  • 11
    Frye MA, Denicoff KD, Bryan AL et al. Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients. Am J Psychiatry 1999; 156: 19091914.
  • 12
    Frye MA, Yatham L, Ketter TA et al. Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies. Acta Psychiatr Scand 2009; 120: 1013.
  • 13
    Sit D. Women and bipolar disorder across the life span. J Am Med Womens Assoc 2004; 59: 91100.
  • 14
    Bocchetta A, Loviselli A. Lithium treatment and thyroid abnormalities. Clin Pract Epidemol Ment Health 2006; 2: 23.
  • 15
    Kupka RW, Nolen WA, Post RM et al. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry 2002; 51: 305311.
  • 16
    Henry C. Lithium side-effects and predictors of hypothyroidism in patients with bipolar disorder: sex differences. J Psychiatry Neurosci 2002; 27: 104107.
  • 17
    Kirov G, Tredget J, John R, Owen MJ, Lazarus JH. A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients. J Affect Disord 2005; 87: 313317.
  • 18
    Kirov G. Thyroid disorders in lithium-treated patients. J Affect Disord 1998; 50: 3340.
  • 19
    Bocchetta A, Mossa P, Velluzzi F, Mariotti S, Del Zompo M, Loviselli A. Ten-year follow-up of thyroid function in lithium patients. J Clin Psychopharmacol 2001; 21: 594598.
  • 20
    Rasgon NL, Kennaa HA, Wongb ML, Whybrow PC, Bauer M. Hypothalamic–pituitary-end organ function in women with bipolar depression. Psychoneuroendocrinology 2007; 32: 279286.
  • 21
    Baskin HJ, Cobin RH, Duick DS et al. Thyroid Task Force, American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002; 8: 457469.
  • 22
    Demers LM, Spencer CA. National Academy of Clinical Biochemistry (NACB): Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease, Volume 13, 2002. Available from: [accessed November 2013].
  • 23
    Cole DP, Thase ME, Mallinger AG et al. Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am J Psychiatry 2002; 159: 116121.
  • 24
    Haggerty JJ Jr, Evans DL, Golden RN, Pedersen CA, Simon JS, Nemeroff CB. The presence of antithyroid antibodies in patients with affective and nonaffective psychiatric disorders. Biol Psychiatry 1990; 27: 5160.
  • 25
    Hornig M, Amsterdam JD, Kamoun M, Goodman DB. Autoantibody disturbances in affective disorders: a function of age and gender? J Affect Disord 1999; 55: 2937.
  • 26
    Vonk R, van der Schot AC, Kahn RS, Nolen WA, Drexhage HA. Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder? Biol Psychiatry 2007; 62: 135140.
  • 27
    Gyulai L, Bauer M, Bauer MS, Garcia-Espana F, Cnaan A, Whybrow PC. Rapid-cycling BD is associated with a latent hypofunction of the HPT system. Biol Psychiatry 2003; 53: 899905.
  • 28
    Van Melick EJ, Wilting I, Meinders AE, Egberts TC. Prevalence and determinants of thyroid disorders in elderly patients with affective disorders: lithium and nonlithium patients. Am J Geriatr Psychiatry 2010; 18: 395403.
  • 29
    Ozsoy S, Mavili E, Aydin M, Turan T, Esel E. Ultrasonically determined thyroid volume and thyroid functions in lithium-naïve and lithium-treated patients with bipolar disorder: a cross-sectional and longitudinal study. Hum Psychopharmacol 2010; 25: 174178.
  • 30
    Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005; 90: 54835488.
  • 31
    Baloch Z, Carayon P, Conte-Devolx B et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13: 3126.
  • 32
    Surks MI, Hollowell JG. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab 2007; 92: 45754582.
  • 33
    Boeving A, Paz-Filho G, Radominski RB, Graf H, Amaral de Carvalho G. Low-normal or high-normal thyrotropin target levels during treatment of hypothyroidism: a prospective, comparative study. Thyroid 2011; 21: 355360.
  • 34
    Barclay ML, Brownlie BE, Turner JG, Wells JE. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol (Oxf) 1994; 40: 759764.
  • 35
    Cizza G, Brady LS, Esclapes ME, Blackman MR, Gold PW, Chrousos GP. Age and gender influence basal and stress-modulated hypothalamic-pituitary-thyroidal function in Fischer 344/N rats. Neuroendocrinology 1996; 64: 440448.
  • 36
    Bottlender R, Rudolf D, Strauss A, Möller HJ. Are low basal serum levels of the thyroid stimulating hormone (b-TSH) a risk factor for switches into states of expansive syndromes (known in Germany as “maniform syndromes” in bipolar I depression)? Pharmacopsychiatry 2000; 33: 7577.
  • 37
    Fagiolini A, Kupfer DJ, Scott J et al. Hypothyroidism in patients with bipolar I disorder treated primarily with lithium. Epidemiol Psichiatr Soc 2006; 15: 123127.
  • 38
    Szuba MP, Amsterdam JD, Fernando AT 3rd, Gary KA, Whybrow PC, Winokur A. Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression. J Clin Psychopharmacol 2005; 25: 325330.
  • 39
    Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T4 and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489499.
  • 40
    Kratzsch J, Fielder GM, Leichtle A et al. New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 2005; 51: 14801486.
  • 41
    Volzke H, Dietrich A, Kohlmann T et al. Reference intervals of serum thyroid function tests in a previously iodine-deficient area. Thyroid 2005; 15: 279285.
  • 42
    Çetinkaya K, İngeç M, Çetinkaya S, Kaplan İ. Iodine deficiency in pregnancy and in women of reproductive age in Erzurum, Turkey. Turk J Med Sci 2012; 42: 675680.
  • 43
    Hollowell JG, Staehling NW, Hannon WH et al. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab 1998; 83: 34013408.